Anhui Fengyuan Pharmaceutical Co Ltd Asset Resilience Ratio
Anhui Fengyuan Pharmaceutical Co Ltd asset resilience ratio. Anhui Fengyuan Pharmaceutical Co Ltd (000153) has an Asset Resilience Ratio of 1.81% as of December 2022. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See Anhui Fengyuan Pharmaceutical Co Ltd defensive liquidity buffer to measure how many days the company can operate on defensive assets alone.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio of Anhui Fengyuan Pharmaceutical Co Ltd (2016–2020)
Asset resilience ratio of Anhui Fengyuan Pharmaceutical Co Ltd from 2016 to 2020. This chart shows how Anhui Fengyuan Pharmaceutical Co Ltd's Asset Resilience Ratio has changed over time. Read 000153 total debt and obligations for a breakdown of total debt and financial obligations.
Liquid Assets Composition Over Time
This chart breaks down Anhui Fengyuan Pharmaceutical Co Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see total assets of Anhui Fengyuan Pharmaceutical Co Ltd.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CN¥0.00 | 0% |
| Short-term Investments | CN¥80.69 Million | 1.81% |
| Total Liquid Assets | CN¥80.69 Million | 1.81% |
Asset Resilience Insights
- Limited Liquidity: Anhui Fengyuan Pharmaceutical Co Ltd maintains only 1.81% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
Anhui Fengyuan Pharmaceutical Co Ltd Industry Peers by Asset Resilience Ratio
Compare Anhui Fengyuan Pharmaceutical Co Ltd's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Takeda Pharmaceutical Company Limited
F:TKDA |
Drug Manufacturers - Specialty & Generic | 0.69% |
|
Takeda Pharmaceutical Co Ltd ADR
NYSE:TAK |
Drug Manufacturers - Specialty & Generic | 4.94% |
|
Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt
F:RIG2 |
Drug Manufacturers - Specialty & Generic | 0.20% |
|
Ajanta Pharma Limited
NSE:AJANTPHARM |
Drug Manufacturers - Specialty & Generic | 14.99% |
|
Changchun High & New Technology Industries Group Inc
SHE:000661 |
Drug Manufacturers - Specialty & Generic | 5.50% |
|
Jiangsu Nhwa Pharmaceutical Co Ltd
SHE:002262 |
Drug Manufacturers - Specialty & Generic | 26.45% |
|
Porton Fine Chemicals Ltd
SHE:300363 |
Drug Manufacturers - Specialty & Generic | 6.85% |
|
Jubilant Pharmova Limited
NSE:JUBLPHARMA |
Drug Manufacturers - Specialty & Generic | 1.26% |
Anhui Fengyuan Pharmaceutical Co Ltd Asset Resilience Ratio by Year (2016–2020)
Anhui Fengyuan Pharmaceutical Co Ltd asset resilience ratio by year from 2016 to 2020. The table below shows the annual Asset Resilience Ratio data for Anhui Fengyuan Pharmaceutical Co Ltd.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2020-12-31 | 0.19% | CN¥6.99 Million ≈ $1.02 Million |
CN¥3.64 Billion ≈ $532.09 Million |
-0.09pp |
| 2019-12-31 | 0.28% | CN¥9.87 Million ≈ $1.44 Million |
CN¥3.56 Billion ≈ $520.88 Million |
+0.02pp |
| 2018-12-31 | 0.26% | CN¥7.79 Million ≈ $1.14 Million |
CN¥3.01 Billion ≈ $440.16 Million |
-0.23pp |
| 2017-12-31 | 0.49% | CN¥13.47 Million ≈ $1.97 Million |
CN¥2.77 Billion ≈ $405.00 Million |
-0.32pp |
| 2016-12-31 | 0.81% | CN¥20.06 Million ≈ $2.94 Million |
CN¥2.49 Billion ≈ $364.42 Million |
-- |
About Anhui Fengyuan Pharmaceutical Co Ltd
Anhui Fengyuan Pharmaceutical Co., Ltd. researches and develops, produces, and sells medicines in China. The company also exports its products. Anhui Fengyuan Pharmaceutical Co., Ltd. was incorporated in 1997 and is based in Hefei, China.